Big Tech on Deck, Musk vs. OpenAI, and Cardiac Drug Breakthroughs 4/27/26

About this episode

The episode discusses the upcoming reports from major tech companies, the trial between Elon Musk and Sam Altman, and advancements in cardiac drug research.

With five of the Mag 7 reporting this week, we discuss whether investors should temper their capex expectations. The trial between Elon Musk and Sam Altman kicks off. Plus, the potential next frontier in preventing heart attacks.

People in this episode

Host: CNBC

Topics covered

• Big Tech
• investing
• heart health
• Elon Musk
• Sam Altman
• capex expectations
• drug breakthroughs

Keywords

• Big Tech
• investing
• Elon Musk
• Sam Altman
• heart attack prevention
• capex
• drug breakthroughs

Mentioned in this episode

Organizations: Mag 7

More episodes of The Exchange

• The Exchange 6/5/26 · June 5, 2026 · 44 min
• The Exchange 6/4/26 · June 4, 2026 · 44 min
• The Exchange 6/3/26 · June 3, 2026 · 57 min
• The Exchange 6/2/26 · June 2, 2026 · 41 min
• The Exchange 6/1/26 · June 1, 2026 · 52 min
• Two Rate Hikes, Tensions Ahead of China Summit, and AI Economic Distortions 5/8/26 · May 8, 2026 · 44 min